Back

The true incidence and risk factors of hemolysis in patients with Impella CP placement

31 August 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Updates on mechanical circulatory support Cardiogenic Shock ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Takahiro Sakai

Saiseikai Kumamoto Hospital, Kumamoto (Japan)

9 More presentations in this session

Presentation thumbnail
Factors associated with 30-day mortality in patients receiving mechanical circulatory support for cardiogenic shock
Miss M. Bogerd (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Direct comparison of mechanical circulatory support devices in porcine model of acute myocardial infarction complicated by ventricular septal defect and cardiogenic shock
Professor P. Ostadal (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
V-A ECMO weaning with pump-controlled retrograde trial off (PCRTO) approach: an illustration of safety, benefits and feasibility
Doctor F. Fiorelli (London, GB)
Abstract Slides Video
Presentation thumbnail
Association between arterial oxygen tension with clinical outcomes in patients undergoing VA-ECMO support: a systematic review and dose-response meta-analysis
Mr M. Ananta (Central Jakarta, ID)
Abstract Slides Video
Presentation thumbnail
Impact of Impella5.0/5.5 use on short-term prognosis in patients with AMI-related cardiogenic shock receiving Impella-incorporated MCS in Japan
Doctor M. Nakamura (Toyama, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Updates on mechanical circulatory support

The Event

Event poster

ESC Congress 2024

31 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Echocardiographic predictors of haemolysis during microaxial flow pump support for cardiogenic shock
thumbnail
Congress Presentation
Prevention and management of bleeding and haemolysis
thumbnail
Congress Presentation
The Impella/mitral valve angle predicts early and late haemolysis in patients receiving Impella support

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources